It’s only fair to share… Tirbanibulin CAS 897016-82-9, 1038395-65-1 DI HCL 1080645-95-9 MESYLATE N-benzyl-2-[5-[4-(2-morpholin-4-ylethoxy)phenyl]pyridin-2-yl]acetamide Molecular Weight 431.53 Formula C₂₆H₂₉N₃O₃ FDA APPROVED 12/14/2020, Klisyri To treat actinic Keratosis of the face or scalp Tirbanibulin (KX2-391) is an inhibitor of Src that targets the peptide substrate site of Src, with GI50 of 9-60 nM in cancer cell lines. Originator Kinex Pharmaceuticals Developer Almirall S.A.; Athenex; Hanmi Pharmaceutical; …